Measuring the benefits of occupational safety and health research with economic metrics: Insights from the National Institute for Occupational Safety and Health.
NIOSH
cost-benefit analysis
occupational safety and health research
prevention effectiveness
strategic research planning
Journal
American journal of industrial medicine
ISSN: 1097-0274
Titre abrégé: Am J Ind Med
Pays: United States
ID NLM: 8101110
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
revised:
29
01
2022
received:
04
11
2021
accepted:
28
02
2022
pubmed:
17
3
2022
medline:
9
4
2022
entrez:
16
3
2022
Statut:
ppublish
Résumé
Measuring the ultimate impact of research on health and economic well-being has presented challenges that have rarely been surmounted, and research on preventing occupational injuries and illnesses is no exception. Nevertheless, there is an increasing need to demonstrate the value of publicly funded research. The National Institute for Occupational Safety and Health (NIOSH) recently contracted with the RAND Corporation to conduct six in-depth case studies that aimed to quantify the benefits of key NIOSH research efforts using economic metrics. These case studies focused on silica exposure in asphalt pavement milling, firefighter cancer risks, a multi-industry matching-grant program for purchase of safety equipment, personal coal dust monitors for coal miners, re-design of ambulance patient compartments for safety, and workplace amputation surveillance. In this article, we summarize what we learned about how measurement of research benefits may be pursued. We summarize the benefit measurement methods that were used and the results of these research efforts in terms of costs saved, injuries and illnesses prevented, and the statistical value of reductions in risk of death or illness. We then distill some observations about the characteristics of research efforts that make measurement of research benefits feasible and suggest steps that could make it feasible to apply the same methods more widely. We also outline key NIOSH activities that appear not to be amenable to benefit measurement but suggest potentials for progress toward at least partial or qualitative benefit assessment. Finally, we discuss implications of the benefit measurement case studies for strategic research planning.
Identifiants
pubmed: 35293636
doi: 10.1002/ajim.23347
pmc: PMC10111360
mid: NIHMS1879424
doi:
Substances chimiques
Coal
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
323-342Subventions
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
MMWR Recomm Rep. 1995 Aug 18;44(RR-10):1-10
pubmed: 7565538
Vaccine. 2019 Jan 7;37(2):226-234
pubmed: 30527660
Am J Ind Med. 2017 Sep;60(9):766-775
pubmed: 28758218
Milbank Q. 2011 Dec;89(4):728-72
pubmed: 22188353
Inj Prev. 2018 Feb;24(1):12-18
pubmed: 28183740
Am J Ind Med. 2014 Oct;57(10):1165-73
pubmed: 25223516
Am J Eval. 2018;40(2):177-189
pubmed: 30518992
Med Care. 2019 Nov;57(11):882-889
pubmed: 31567863
Am J Ind Med. 2021 Jan;64(1):3-12
pubmed: 33231875
Am J Ind Med. 2019 Dec;62(12):1117-1134
pubmed: 31520453
Ann Work Expo Health. 2019 Apr 19;63(4):375-385
pubmed: 30916322
Med Care. 2009 Jul;47(7 Suppl 1):S94-103
pubmed: 19536021
Sex Transm Dis. 2018 Jan;45(1):2-7
pubmed: 29240632
Health Care Financ Rev. 1985 Fall;7(1):61-80
pubmed: 10311399
Science. 2012 May 18;336(6083):907-11
pubmed: 22605775
Rand Health Q. 2018 Aug 2;8(1):1
pubmed: 30083422
Am J Ind Med. 2016 Nov;59(11):919-933
pubmed: 27273383